E88.11

Clinical Causes: Acquired partial lipodystrophy (APL), also known as Barraquer-Simons lipodystrophy, where fat loss develops over time without a clear inherited pattern. Familial partial lipodystrophy (FPLD), which is inherited and often follows patterns associated with specific genetic mutations. Autoimmune processes that may target fat tissue, leading to its localized loss. Certain medications or medical conditions that may indirectly contribute to fat tissue loss. Genetic mutations affecting adipose tissue function or development in familial cases.

Key Symptoms: Localized fat loss in parts of the body, commonly involving the face, arms, and legs. Preservation of fat in other areas, such as the abdomen or trunk. Development of muscularity or visible veins in areas where fat has diminished. Potential metabolic issues like insulin resistance, hyperglycemia, or abnormal lipid profiles. Changes in body shape that can impact self-esteem or physical comfort. In some cases, skin may appear thin or atrophic in affected regions.

Diagnosis Path: Detailed physical assessment focusing on fat distribution and body contour. Blood tests to evaluate metabolic parameters, including blood sugar, cholesterol, and triglyceride levels. Imaging studies, such as MRI or CT scans, to visualize fat loss in specific areas. Genetic testing, particularly in familial cases, to identify known mutations associated with lipodystrophy. Histopathological examination of fat tissue in some cases to assess tissue characteristics.

Treatment Protocols: Lifestyle modifications, such as a balanced diet and regular exercise, to improve metabolic health. Medications to control high blood sugar and lipid levels, including insulin sensitizers, statins, or fibrates. Reconstructive surgeries or cosmetic procedures may be considered to improve body contour. Monitoring and management of associated conditions, such as diabetes or cardiovascular disease. Supportive care and counseling to help cope with aesthetic changes and emotional effects.